invest in glp-1 Weight loss drugs and stocks: Breaking down the GLP1 market for investors GLP-1 Agonists Market Report 2025-2033,

The medication works by imitating a blood sugar and insulin-controlling hormone produced in the body, which makes you feel full

But there's a side effect most people aren't warned about: you're losing muscle, not just fat

As a new hypoglycemic agent, GLP-1RA enhances insulin sensitivity, reduces body weight and protects the cardiovascular system (62)

Elemam NM, Hannawi S, Maghazachi AA

Research shows that heart rate elevation typically occurs during the initial dose escalation phase, not at maintenance doses

Some wonder if this compound is better suited for metabolic versus behavioral studies, or if it's applicable to neuroendocrine pathways